Biotricity, Inc. (BTCY)
NASDAQ: BTCY · IEX Real-Time Price · USD
0.851
-0.009 (-1.05%)
At close: Nov 28, 2023, 3:11 PM
0.850
-0.001 (-0.13%)
After-hours: Nov 28, 2023, 4:00 PM EST
Biotricity Market Cap
Biotricity has a market cap or net worth of $7.10 million as of November 28, 2023. Its market cap has decreased by -87.49% in one year.
Market Cap
7.10M
Enterprise Value
27.57M
1-Year Change
-87.49%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since February 16, 2018, Biotricity's market cap has decreased from $94.90M to $7.10M, a decrease of -92.51%. That is a compound annual growth rate of -36.14%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 27, 2023 | 7.50M | -7.41% |
Nov 24, 2023 | 8.10M | 5.19% |
Nov 22, 2023 | 7.70M | -3.75% |
Nov 21, 2023 | 8.00M | -3.61% |
Nov 20, 2023 | 8.30M | -4.60% |
Nov 17, 2023 | 8.70M | 4.82% |
Nov 16, 2023 | 8.30M | 5.06% |
Nov 15, 2023 | 7.90M | - |
Nov 14, 2023 | 7.90M | 11.27% |
Nov 13, 2023 | 7.10M | -4.05% |
Nov 10, 2023 | 7.40M | 7.25% |
Nov 9, 2023 | 6.90M | -6.76% |
Nov 8, 2023 | 7.40M | -3.90% |
Nov 7, 2023 | 7.70M | -2.53% |
Nov 6, 2023 | 7.90M | -3.66% |
Nov 3, 2023 | 8.20M | -2.38% |
Nov 2, 2023 | 8.40M | 1.20% |
Nov 1, 2023 | 8.30M | -8.79% |
Oct 31, 2023 | 9.10M | -2.15% |
Oct 30, 2023 | 9.30M | -19.83% |
Oct 27, 2023 | 11.60M | -27.95% |
Oct 26, 2023 | 16.10M | 1.90% |
Oct 25, 2023 | 15.80M | -5.95% |
Oct 24, 2023 | 16.80M | 2.44% |
Oct 23, 2023 | 16.40M | -1.80% |
View and export this data all the way back to 2018.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Can-Fite BioPharma | 8.33M |
ENDRA Life Sciences | 8.33M |
Imunon | 8.27M |
Benitec Biopharma | 8.23M |
Shuttle Pharmaceuticals Holdings | 8.16M |
Acutus Medical | 8.09M |
Galera Therapeutics | 7.86M |
iBio, Inc. | 7.86M |